| Market Capitalization (Millions $) |
98 |
| Shares
Outstanding (Millions) |
71 |
| Employees |
110 |
| Revenues (TTM) (Millions $) |
40 |
| Net Income (TTM) (Millions $) |
-103 |
| Cash Flow (TTM) (Millions $) |
-38 |
| Capital Exp. (TTM) (Millions $) |
0 |
C4 Therapeutics Inc
C4 Therapeutics Inc is a biotechnology company that specializes in developing novel therapeutics based on targeted protein degradation. They aim to pioneer a new class of drugs known as Degronimid' molecules, which selectively eliminate disease-causing proteins within the cell. By harnessing the natural protein disposal system called the ubiquitin-proteasome system, C4 Therapeutics hopes to address a wide range of diseases, including cancer and neurodegenerative disorders. Their approach has the potential to provide more effective and safer treatment options for patients.
Company Address: 490 Arsenal Way Watertown 2472 MA
Company Phone Number: 231-0700 Stock Exchange / Ticker: NASDAQ CCCC
|
0.000%
2% 
43.56 %